Generics - Pharmaceutical, Politics

Filter

Current filters:

PharmaceuticalPolitics

Popular Filters

1 to 25 of 29 results

India takes action on spurious and sub-standard drugs

India takes action on spurious and sub-standard drugs

10-11-2014

An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals…

GenericsIndiaMarkets & MarketingPharmaceuticalPoliticsRegulation

PhRMA slams US President’s claims that Budget invests in innovation

06-03-2014

Pharmaceutical Research and Manufacturers of America (PhRMA) president and chief executive John Castellani…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsResearchUSA

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions

05-08-2013

In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

Tightening health budgets on both sides of the Atlantic leading to crackdowns on patent settlements, says EIU analyst

05-06-2013

Later this month, following an inquiry launched in 2009, the European Commission is expected to impose…

EuropeFinancialGenericsNorth AmericaPatentsPharmaceuticalPoliticsRegulation

Government health care reforms foster development China's Pharma market, says F&S

28-05-2013

Rising incomes, improving health care infrastructure and enhanced insurance systems have propelled the…

Asia-PacificGenericsHealthcareMarkets & MarketingPatentsPharmaceuticalPolitics

Italy's pharma market slump set to continue, warns GlobalData

22-05-2013

The value of Italy's pharmaceutical market will continue to fall in the foreseeable future, due to government…

EuropeGenericsMarkets & MarketingPharmaceuticalPoliticsPricing

Australia's 2013-14 Budget includes investment in health services and PBS

14-05-2013

The Australian government today (May 14) presented its Budget for 2013-2014, saying that it delivers…

Asia-PacificFinancialGenericsPharmaceuticalPoliticsPricing

Countries must fix critical access to medicines flaws in Trans-Pacific Trade Pact, says MSF

14-05-2013

As negotiations for the Trans-Pacific Partnership (TPP) restart in Lima, Peru, tomorrow (May 15), countries…

GenericsPatentsPharmaceuticalPoliticsPricing

Activists protest in front of the European Parliament to stop EU-India trade deal "harmful" provisions

09-04-2013

As European Commission pressure mounts on India to rush into signing a free trade agreement (FTA) by…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPoliticsPricing

DNP+ and MSF urge India to reject EU demands on trade deal before April deadline

13-03-2013

Pressure is mounting on India to quickly sign off on a free trade agreement with the European Union which…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPolitics

Ukraine pharma industry appeals to President on some new drug law provisions

18-02-2013

Ukraine's Association of Pharmaceutical Research and Development, APRAD, has written to the country's…

EuropeGenericsLegalPharmaceuticalPolitics

Global Pharma may leave Russian market due to protectionist policies

17-02-2013

The planned imposition of restrictions for the public purchase of imported drugs, initiated by the Russian…

EuropeGenericsMarkets & MarketingPharmaceuticalPoliticsRegulation

Mixed views from PhRMA and GPhA on Obama's State of the Union Address

15-02-2013

There were mixed reactions from two sides of the US drug industry - research-based and generic drugmakers…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPolitics

Indian government endorses plan to cap prices of 348 drugs

23-11-2012

India's Union Cabinet yesterday endorsed the Group of Ministers' (GoM) recommendations on the National…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

Indian govt pressed to adopt market-based drug pricing by ASSOCHAM

22-11-2012

India's Associated Chambers of Commerce and Industry (ASSOCHAM) believes that the Supreme Court ruling…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

Japan's dilemma: Generics vs long-listed brands, by P Reed Maurer

30-10-2012

In most countries, promoting generics to save money in the health care budget is considered good policy.…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

Indonesian government overrides patents on seven HIV and hepatitis drugs

15-10-2012

In a move that was announced in early September but which just came to light last week, the government…

Anti-viralsGenericsPatentsPharmaceuticalPoliticsPricing

India finalizes pharma pricing policy, which will cover 348 drugs

28-09-2012

India's Group of Ministers (GoM), headed by Agriculture Minister Sharad Pawar, yesterday finalized the…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

Pharma vs the world: Big Pharma caught between investors and public

23-09-2012

Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Indian pharma traders urge government to speed up national drug pricing policy

19-09-2012

The All India Organization of Chemists and Druggists (AIOCD) - the single largest body of the drug traders…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

PhRMA disputes Indian claims relating to cancer drug shortages

27-08-2012

In a recent interview with Times of India, a trade association that represents several major generic…

Asia-PacificGenericsNorth AmericaPatentsPharmaceuticalPolitics

US House of Reps Passes FDA Reform Act

01-06-2012

Just days after the US Senate overwhelming approved the Food and Drug Administration Safety and Innovation…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

EU draft opinion on ACTA still flawed, says MSF, urging member states not to sign

11-05-2012

The European Union Parliament Committee on Development released its draft opinion this week on the Anti-Counterfeiting…

EuropeGenericsGlobalPatentsPharmaceuticalPolitics

Consumer groups call for condemnation of ACTA independent of ECJ

27-03-2012

Health-related consumer groups Health Action International (HAI) Europe, Oxfam, Medecins Sans Frontieres…

EuropeGenericsGlobalLegalPatentsPharmaceuticalPoliticsRegulation

1 to 25 of 29 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top